Pediatr. praxi 2019; 20(2): 78-81 | DOI: 10.36290/ped.2019.017

Treatment options for viral infections in children

MUDr. Hana Zelená
Oddělení virologie, Centrum klinických laboratoří, Zdravotní ústav se sídlem v Ostravě

At present, a number of viral diseases can be treated causally with antiviral drugs. The indications of antiviral drugs are limited by a restricted spectrum of available agents and their pharmaceutical forms, toxicity, high cost, and, in children, even by age restrictions. They are administered primarily in viral infections with a severe course and immune-deficient persons. The dosage and pharmaceutical form depend on the infective agent and disease severity. Antiviral drugs have been approved for the treatment of HIV infection, hepatitis B and C, influenza, some herpesviruses, and RS viruses. In the off-label setting, they are even used in treating other severe viral infections. In prophylactic indications, a specific hyperimmune immunoglobulin is available for VZV, and a humanized monoclonal antibody can be used for RSV prophylaxis. The article summarizes the options of administering these agents, with a particular focus on the use in the paediatric population.

Keywords: viral disease, treatment, antiviral drugs, vaccination

Published: April 23, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zelená H. Treatment options for viral infections in children. Pediatr. praxi. 2019;20(2):78-81. doi: 10.36290/ped.2019.017.
Download citation

References

  1. Beneš Jiří. Infekční lékařství. Praha: Galén, 2009: 651s.
  2. Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc, 2011, 86, p. 1009-1026 Go to original source...
  3. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004; 17: 1-13. Go to original source...
  4. McClain L, et al. Broad-spectrum non-nucleoside inhibitors of human herpesviruses. Antiviral Res. 2015; 121: 16-23. Go to original source...
  5. Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007; 6: 1015-1028. Go to original source...
  6. Rozsypal H. Antivirotika proti herpetickým virům. Zdravotnictví a medicína 2013 [online]. Dostupné z: https://zdravi.euro.cz/clanek/postgradualni-medicina/antivirotika-proti-herpetickym-virum-472471
  7. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014; 348: g2545. Go to original source... Go to PubMed...
  8. Lee J, Park JH, Jwa H, Kim YH. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis. Yonsei Med J. 2017; 58(4): 778-785. Go to original source... Go to PubMed...
  9. Hama R, Bennett CL. The mechanisms of sudden-onset type adverse reactions to oseltamivir. Acta Neurol Scand. 2016; 135(2): 148-160. Go to original source... Go to PubMed...
  10. Fernandez H, Banks G, Smith R. Ribavirin: a clinical overview. Eur J Epidemiol. 1986; 2: 1-14. Go to original source...
  11. Antonen J, Leppanen I, Tenhunen J, Arvola P, Makela S, Vaheri A, Mustonen J. A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand J Infect, DiS. 2013; 45: 494-496. Go to original source... Go to PubMed...
  12. Teissier N, Bernard S, Quesnel S, Van Den Abbeele T. Audiovestibular consequences of congenital cytomegalovirus infection. Eur Ann Otorhinolaryngol Head Neck, DiS. 2016 Dec; 133(6): 413-418. Go to original source...
  13. SPC - Souhrn údajů o přípravku. herpesin-250-spc.pdf sp.zn. sukls178224/2013 Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0155939&tab=texts
  14. SPC - Souhrn údajů o přípravku. herpesin-250-spc.pdf sp.zn. sukls178223/2013, sp.zn. sukls178225/2013 Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0155938&tab=texts
  15. SPC - Souhrn údajů o přípravku. cymevene-spc. pdf sp.zn. sukls104672/2017, 251711/2017 Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0016547&tab=texts
  16. SPC - Souhrn údajů o přípravku. tamiflu-epar-product-information cs. Dostupné z: https://www.ema.europa.eu/documents/product-information/tamiflu-epar-product-information_cs.pdf
  17. SPC - Souhrn údajů o přípravku. rebetol-epar-product-information cs. Dostupné z: https://www.ema.europa.eu/documents/product-information/rebetol-epar-product-information_cs.pdf
  18. SPC - Souhrn údajů o přípravku. synagis-epar-product-information cs. Dostupné z: https://www.ema.europa.eu/documents/product-information/synagis-epar-product-information_cs.pdf
  19. SPC - Souhrn údajů o přípravku. mabthera-epar-product-information cs. Dostupné z: https://www.ema.europa.eu/documents/product-information/mabthera-epar-product-information_cs.pdf




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.